Therefore, the reason for the myelin loss-reducing effect of ghrelin may be due to its suppression of MDA levels in the cuprizone-induced MS model and it has antioxidant, ROS-reducing and mitochondrial dysfunction-regulating effects. Here, GHRL is linked to myeloid sarcoma.